Thyroid cancer
Conditions
Interventions
None listed
Sponsors
Nagasaki University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients who are administered I-131 for therapeutic purpose in isolation room.
Exclusion criteria
Exclusion criteria: Patients who are pregnant or possibly pregnant. Patients who are performing breast feeding to baby.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Changes of DNA damage between bef ore I-131 administration and three days after administration. | — |
Secondary
| Measure | Time frame |
|---|---|
| correlation between DNA damage and blood sample data/history/therapeutic record/I-131 dose/emitted radiation dose from patient. | — |
Countries
Japan
Contacts
Public ContactTakashi Kudo
Nagasaki University Department of Radioisotope Medicine, Atomic Bomb Disease Institute
Outcome results
None listed